Grape King Bio Ltd (1707)

Currency in TWD
130.00
+0.50(+0.39%)
Closed·
1707 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Earnings results expected in 5 days
Fair Value
Day's Range
128.00130.50
52 wk Range
119.50158.00
Key Statistics
Bid/Ask
168.00 / 168.50
Prev. Close
141
Open
128
Day's Range
128-130.5
52 wk Range
119.5-158
Volume
61.75K
Average Volume (3m)
172.24K
1-Year Change
-8.45%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
1707 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
188.00
Upside
+44.62%
Members' Sentiments
Bearish
Bullish
ProTips
Impressive gross profit margins

Grape King Bio Ltd News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Sell

Grape King Bio Ltd Company Profile

Grape King Bio Ltd, together with its subsidiaries, produces and sells pharmaceutical preparations, patent medicines, liquid tonics, drinks, and healthy food in Taiwan, China, and internationally. It operates through Multi-Level Marketing; Distributors; Original Design Manufacturer/Original Equipment Manufacturer; and Sales Channel segments. The company offers Chinese herbal medicines, probiotics, energy drinks, and health food supplements for gastrointestinal health, immunity regulation, female beauty, and health care. It also provides functional ingredients for intestinal care, weight control, liver care, brain health, eye care, feminine health, and sensual health care; and microbial fermentation, as well as food inspection services. In addition, the company offers health foods, beverages, cosmetics, and general and pet food. Grape King Bio Ltd was founded in 1969 and is headquartered in Taoyuan City, Taiwan.

Employees
501
Market
Taiwan

Compare 1707 to Peers and Sector

Metrics to compare
1707
Peers
Sector
Relationship
P/E Ratio
13.8x38.3x12.1x
PEG Ratio
−6.31−1.490.03
Price/Book
2.0x1.8x1.5x
Price / LTM Sales
1.7x1.7x0.9x
Upside (Analyst Target)
44.6%0.5%17.9%
Fair Value Upside
Unlock20.2%11.2%Unlock

Analyst Ratings

1 Buy
1 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 188.00
(+44.62% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 9.44%
Dividend Yield
5.31%
Industry Median 3.67%
Annualised payout
6.90
Paid annually
5-Years Growth
+1.20%
Growth Streak

Earnings

Latest Release
May 07, 2025
EPS / Forecast
1.40 / 1.90
Revenue / Forecast
2.25B / 2.50B
EPS Revisions
Last 90 days

1707 Income Statement

FAQ

What Stock Exchange Does Grape King Bio Trade On?

Grape King Bio is listed and trades on the Taiwan Stock Exchange stock exchange.

What Is the Stock Symbol for Grape King Bio?

The stock symbol for Grape King Bio is "1707."

What Is the Grape King Bio Market Cap?

As of today, Grape King Bio market cap is 19.26B.

What Is Grape King Bio's Earnings Per Share (TTM)?

The Grape King Bio EPS (TTM) is 9.44.

When Is the Next Grape King Bio Earnings Date?

Grape King Bio will release its next earnings report on 07 Aug 2025.

From a Technical Analysis Perspective, Is 1707 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Grape King Bio Stock Split?

Grape King Bio has split 4 times.

How Many Employees Does Grape King Bio Have?

Grape King Bio has 501 employees.

What is the current trading status of Grape King Bio (1707)?

As of 03 Aug 2025, Grape King Bio (1707) is trading at a price of 130.00, with a previous close of 141.00. The stock has fluctuated within a day range of 128.00 to 130.50, while its 52-week range spans from 119.50 to 158.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.